ClinicalTrials.Veeva

Menu

Using Antibiotics Wisely - An Antimicrobial Stewardship Program

University of British Columbia logo

University of British Columbia

Status

Enrolling

Conditions

Late-Onset Sepsis, Neonatal
Antimicrobial Resistance
Multi-Drug Resistant Organisms

Treatments

Other: Exposure of interest

Study type

Observational

Funder types

Other

Identifiers

NCT04388293
H19-02490

Details and patient eligibility

About

There are significant variations in antimicrobial consumption across Canadian Neonatal Intensive Care Units (NICUs). Inappropriate and overuse of antibiotics can result in antimicrobial resistance and adverse outcomes among vulnerable neonatal populations. There are limited data on broad-spectrum antimicrobial use, multi-drug resistant organisms (MDRO) prevalence, and effective NICU-specific antimicrobial stewardship strategies. The aim of this study is to develop and implement NICU-specific antimicrobial stewardship strategies at both national and individual unit levels to promote optimal antimicrobial use and decrease the incidence of MDROs.

Full description

Purpose: The investigators aim to develop and implement NICU-specific Antimicrobial Stewardship Program (ASP) strategies at both national and individual unit levels to promote optimal antimicrobial use and decrease the incidence of multi-drug resistant organisms (MDRO) in Canada.

Hypothesis: The investigators expect to find:

  • Significant national variation in broad-spectrum antimicrobial use, which will not be correlated with rates of sepsis. High antimicrobial consumption rates may be associated with limited existing ASP resources and increased neonatal morbidity related to inflammatory cascades.
  • Significant national variation in the prevalence of MDROs across NICUs.
  • Differences in empirical antimicrobial regimens may be associated with MDRO prevalence, and the variation in antimicrobial use may explain some variation in neonatal morbidity.

Study Population and Sample Size: The study population will include very-low-birth-weight (VLBW) infants (i.e., the group of infants neonates with the highest risk of infections within NICUs) admitted to participating tertiary NICUs in Canada.

Enrollment

2,000 estimated patients

Sex

All

Ages

22 to 44 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Very-low-birth-weight infants admitted to participating tertiary NICUs in Canada.

Exclusion criteria

  • infants with major congenital anomalies

Trial contacts and locations

1

Loading...

Central trial contact

Joseph Ting, Associate Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems